SKINBIOTIX LIMITED

Active Newcastle Upon Tyne

Other human health activities

0 employees website.com
Life sciences and medical technology Other human health activities
S

SKINBIOTIX LIMITED

Other human health activities

Founded 5 Jan 2017 Active Newcastle Upon Tyne, England 0 employees website.com
Life sciences and medical technology Other human health activities
Accounts Submitted 25 Mar 2026 Next due 31 Mar 2026 1 month overdue
Confirmation Submitted 14 Jan 2026 Next due 18 Jan 2027 8 months remaining
Net assets £1 £0 2024 year on year
Total assets £1 £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Core Bath Lane Newcastle Helix Newcastle Upon Tyne NE4 5TF England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SKINBIOTIX LIMITED (10549152), an active life sciences and medical technology company based in Newcastle Upon Tyne, England. Incorporated 5 Jan 2017. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

£1.00

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Simon Jonathan HewitsonDirectorBritishUnited Kingdom5028 Apr 2025Active

Shareholders

Shareholders (1)

Skinbiotherapeutics Plc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 5 Jan 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

SKINBIOTIX LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
25 Mar 2026AccountsAnnual accounts made up to 30 Jun 2025
20 Mar 2026OfficersAppointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026
13 Feb 2026OfficersTermination of Stuart John Ashman as director on 13 Feb 2026
14 Jan 2026OfficersAppointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026
14 Jan 2026Confirmation StatementConfirmation statement made on 4 Jan 2026 with no updates
25 Mar 2026 Accounts

Annual accounts made up to 30 Jun 2025

20 Mar 2026 Officers

Appointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026

13 Feb 2026 Officers

Termination of Stuart John Ashman as director on 13 Feb 2026

14 Jan 2026 Officers

Appointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026

14 Jan 2026 Confirmation Statement

Confirmation statement made on 4 Jan 2026 with no updates

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

1 months ago on 25 Mar 2026

Appointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026

1 months ago on 20 Mar 2026

Termination of Stuart John Ashman as director on 13 Feb 2026

2 months ago on 13 Feb 2026

Appointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026

3 months ago on 14 Jan 2026

Confirmation statement made on 4 Jan 2026 with no updates

3 months ago on 14 Jan 2026